Screener
Upstream Bio, Inc. UPB Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $79,397 | $101,578 |
| Short-term investments | 181,910 | 239,931 |
| Accounts receivable | 772 | 668 |
| Prepaid expenses and other current assets | 17,523 | 9,620 |
| Total current assets | 279,602 | 351,797 |
| Property and equipment, net | 460 | 559 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s short-term investments?
- Upstream Bio, Inc. (UPB) reported short-term investments of $181.91M in Q2 2026.
- How has Upstream Bio, Inc.'s short-term investments changed year-over-year?
- Upstream Bio, Inc.'s short-term investments decreased by 47.7% year-over-year, from $348.12M to $181.91M.
- What is the long-term trend for Upstream Bio, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s short-term investments has grown at a 69.0% compound annual growth rate (CAGR), from $83.98M to $239.93M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Upstream Bio, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude